ArticlePain reports2026
Long-term outcomes of microvascular decompression vs neurotomy for glossopharyngeal neuralgia: a multicenter clinimetric study.
Article in Pain reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Glossopharyngeal neuralgia (GPN) is a rare cranial pain syndrome, with limited comparative long-term evidence for microvascular decompression (MVD) and neurotomy (NT). Objectives: To compare clinimetric outcomes of microvascular decompression (MVD) and neurotomy (NT) in patients with glossopharyngeal neuralgia (GPN). Methods: Analytical ambispective multicenter study (1990-2024) including patients with GPN treated with MVD or NT across 3 international neurosurgical centers. Pharmacological treatment history was recorded. Pain intensity was assessed pre- and postoperatively using the Visual Analog Scale (VAS) and Barrow Neurological Institute-Pain Intensity Score. Positive sensory symptoms (PSS) including allodynia, dysesthesia, and paresthesia were evaluated when data were available. Results: From a total of 93 medical records, 25 patients underwent surgery; 23 met inclusion criteria (MVD = 12, NT = 11) and were evaluated long-term. Patients had a mean age of 58.48 ± 14.33 years, and follow-up ranged from 6 months to 14 years (mean 5.2 ± 4.52). All patients were refractory to pharmacotherapy. Overall VAS scores decreased from 4 to 10 (mode 10) preoperatively to 0 to 5 (mode 0) postoperatively ( Conclusions: Both MVD and NT are highly effective in reducing pain and PSS in GPN, with comparable postoperative outcomes. Limitations include small sample size and ambispective design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.